Trial Profile
Efficacy and safety of subsequent treatment with 90Y-Zevalin in patients with stage II to IV follicular non-Hodgkin's lymphoma in partial or complete remission after oral fludarabine and mitoxantrone front-line treatment. A phase II prospective, multicenter, open-label study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Jun 2011
Price :
$35
*
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Fludarabine; Mitoxantrone
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms FLUMIZ
- 05 Nov 2010 New trial record.